Concepedia

Johannes Selbach

JS

11

Publications

346

Citations

10

H-Index

1989

Active since

Affiliations

Roche Pharma AG (Germany)(Current)

Klinikum Kassel

Nuremberg Hospital

Roche (Switzerland)

Klinikum Lüneburg

Johannes Selbach is an author at Roche Pharma AG (Germany) specializing in oncology, medicine, and pathology.

Top concepts

Publications per year

1989–2018

11

Publications

11

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 101 citations · Full text

, , +8

Karyotype in multiple myeloma and plasma cell leukaemia

Hans Josef Weh, K. Gutensohn, Johannes Selbach et al. · European Journal of Cancer · 1993 · 83 citations

, , +8

Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany

Peter Dall, G Lenzen, Thomas Göhler et al. · Journal of Geriatric Oncology · 2015 · 34 citations

Correlations between karyotype and cytologic findings in multiple myeloma.

H.J. Weh, R. Bartl, Doris R. Seeger et al. · PubMed · 1995 · 30 citations

Impact of trastuzumab treatment beyond disease progression for advanced/metastatic breast cancer on survival – Results from a prospective, observational study in Germany

Christian Jackisch, Manfred Welslau, Winfried Schoenegg et al. · The Breast · 2014 · 19 citations

Rows per page

1–5 of 11